Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain Drug
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
bovnews1d
What’s Fueling Xpeng Inc – ADR (XPEV) Stock’s 48.77% Gain Above Its 200-Day SMA?
ADR (XPEV) stock saw a decline, ending the day at $14.81 which represents a decrease of $-0.30 or -1.99% from the prior close of $15.11. The stock opened at $15.23 and touched a low of $14.75 during ...
XPeng put volume heavy and directionally bearish
Bearish flow noted in XPeng (XPEV) with 3,719 puts trading, or 1.7x expected. Most active are 1/31 weekly 15.5 puts and Mar-25 12 puts, with ...
Hosted on MSN3d
XPeng Inc. Sponsored ADR (XPEV) Increases Yet Falls Behind Market: What Investors Need to Know
The most recent trading session ended with XPeng Inc. Sponsored ADR (XPEV) standing at $15.11, reflecting a +0.13% shift from the previouse trading day's closing. The stock fell short of the S&P 500, ...
Check Out What Whales Are Doing With XPEV
With a volume of 4,148,281, the price of XPEV is up 0.07% at $15.1. RSI indicators hint that the underlying stock is ...